Skip to contentN
Nutra Pharma Corp
N
NPHCNutra Pharma Corp Q1 2018 · 10-Q
Revenue$32.48K$32.48K+91.3% vs Q1 2017 Net Income-$4.09M-$4.09MN/M vs Q1 2017 EPS Diluted$0.00$0.00N/M vs Q1 2017 Gross Profit$26,617+189.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
Operating Cash Flow-$348,314N/M Margins · derivedGross margin82.0%+27.9 pt vs Q1 2017
Operating margin-1039.1%+1423.0 pt vs Q1 2017
Net margin-12589.2%−7052.1 pt vs Q1 2017
ended Mar 31, 2018 · filed May 21, 2018 · 51 d after period end